Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Partilla

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2016
Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in RatsJoshua S Elmore, Ora Dillon-Carter, John S Partilla, et al.
Brain Research Bulletin|July 22, 2008
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptorsHeng Xu, Xiaoying Wang, John S Partilla, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 16, 2014
'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter functionKusumika Saha, John S Partilla, Kurt R Lehner, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2003
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substratesRichard B Rothman, Nga Vu, John S Partilla, et al.
Drug and Alcohol Dependence|December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterMaarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 23, 2017
N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse LiabilityErnesto Solis, John S Partilla, Farhana Sakloth, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 30, 2013
Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substratesMichael H Baumann, Simon Bulling, Tova S Benaderet, et al.
Drug Testing and Analysis|August 16, 2016
Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedroneGavin McLaughlin, Noreen Morris, Pierce V Kavanagh, et al.
Journal of Medicinal Chemistry|June 22, 2007
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analoguesDenise S Simpson, Peter L Katavic, Anthony Lozama, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 16, 2011
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissueMichael H Baumann, Mario A Ayestas, John S Partilla, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2016
Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in RatsJoshua S Elmore, Ora Dillon-Carter, John S Partilla, et al.
Brain Research Bulletin|July 22, 2008
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptorsHeng Xu, Xiaoying Wang, John S Partilla, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 16, 2014
'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter functionKusumika Saha, John S Partilla, Kurt R Lehner, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2003
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substratesRichard B Rothman, Nga Vu, John S Partilla, et al.
Drug and Alcohol Dependence|December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterMaarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 23, 2017
N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse LiabilityErnesto Solis, John S Partilla, Farhana Sakloth, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 30, 2013
Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substratesMichael H Baumann, Simon Bulling, Tova S Benaderet, et al.
Drug Testing and Analysis|August 16, 2016
Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedroneGavin McLaughlin, Noreen Morris, Pierce V Kavanagh, et al.
Journal of Medicinal Chemistry|June 22, 2007
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analoguesDenise S Simpson, Peter L Katavic, Anthony Lozama, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 16, 2011
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissueMichael H Baumann, Mario A Ayestas, John S Partilla, et al.
Pageof 7